bioRxiv Science⌕ Search

bioRxiv · 10.64898/2025.11.30.691458

Modeling the structure-conditioned sequence landscape for large-scale protein design with TriFlow

Abstract

Generative models have revolutionized computational protein design, and the design of high-quality sequences given backbone structure is a critical component for success. Current state-of-the-art design pipelines utilize sequence design methods with local structural context and autoregressive generation. To improve efficiency and quality of sequence design, we developed TriFlow, a model that combines a RoseTTAFold-like three-track architecture for global structural context with discrete flow-matching for efficient few-step sequence generation. We trained TriFlow on a large dataset of interacting protein chains from Protein Data Bank and interacting domains from AlphaFold protein structure Database to enrich its knowledge of natural protein and domain interfaces. TriFlow outperforms existing sequence design methods like ProteinMPNN across diverse benchmarks, including de novo binder design, where it boosts the in silico success rate of state-of-the-art design pipelines such as BindCraft. We demonstrated this by conducting a large-scale benchmark, generating and computationally validating binders for over 500 diverse protein targets. Experimental validation on a small set of targets also suggests that the performance of TriFlow is on par with BindCraft. By leveraging the model to explore the designed sequence landscape, we discovered that we can effectively highlight functional sites, by contrasting designed sequences that reflect structure constraints with natural evolutionary profiles. As a practical demonstration of its capabilities, we applied our pipeline to systematically design specific binders against human class I cytokines, computationally optimizing for on-target affinity while minimizing off-target interactions, demonstrating that specificity also scales with inference time and computational budget. TriFlow thus provides a robust framework both for large-scale protein engineering and for exploring the fundamental principles of the structure-conditioned sequence landscape. TriFlow software and generated resources are available at https://triflow.zhoulab.io/.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Srinivasan, H., Yuan, R., Cong, Q., Zhou, J.. 2025-12-02. Modeling the structure-conditioned sequence landscape for large-scale protein design with TriFlow. https://doi.org/10.64898/2025.11.30.691458

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease

Aims: Premature coronary artery disease (PCAD) lacks specific molecular drivers, and the role of immunosenescence is unclear. We investigated whether aging-related gene dysregulation in T cells contributes to PCAD. Methods: We combined bulk transcriptomics of PBMCs from 12 PCAD patients and 21 controls, single-cell RNA sequencing of PBMCs and human atherosclerotic plaques, weighted gene co-expression network analysis, gene perturbation network analysis, and molecular docking. Results: KRAS was identified as a hub gene intersecting PCAD-associated genes and aging-related genes. Single-cell analysis showed KRAS upregulation predominantly in effector CD8+ T cells, which exhibited the highest senescence scores that were further elevated in disease. Network perturbation of KRAS strongly impacted the cell killing pathway. KRAS-high effector CD8+ T cells were detected in coronary and carotid plaques, displaying enhanced cytotoxicity, exhaustion, and senescence features. Additionally, a candidate small molecule was computationally predicted to bind inactive KRAS. Conclusions: Elevated KRAS expression in senescent, cytotoxic CD8+ T cells is associated with PCAD, bridging immunosenescence and premature atherosclerosis. This finding provides a novel biomarker candidate and potential therapeutic entry point, awaiting further functional validation.

bioinformatics↗

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗